Development of a small cell lung cancer organoid model to study cellular interactions and survival after chemotherapy

By sjmartinez • August 23, 2023

Sen C, Koloff CR, Kundu S, Wilkinson DC, Yang JM, Shia DW, Meneses LK, Rickabaugh TM, Gomperts BN. Development of a small cell lung cancer organoid model to study cellular interactions and survival after chemotherapy. Front Pharmacol. 2023 Aug 7;14:1211026. doi: 10.3389/fphar.2023.1211026. PMID: 37608896; PMCID: PMC10441219.

Tags: 3D model, cancer organoids, chemotherapy, conditioned media, image processing, lung fibroblast, phenotypic tool, Publications, Pulmonary, Critical Care & Sleep Medicine, survival

Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review

Leiva O, Liu O, Kanelidis A, Swat S, Gozdecki L, Belkin M, Grinstein J, Kalantari S, Kim G, DeCara J, Chung B, Patel A, Odenike[...]

Self-Reported Resilience During the COVID-19 Pandemic

Ogungbe O, Wang T, Balte PP, Slone SE, Meyer D, Allen NB, Buhr RG, Hirsch JA, Hinckley Stukovsky K, Kucharska-Newton A, Gabriel KP, Regan EA,[...]

Estimating efficacy of favezelimab plus pembrolizumab relative to pembrolizumab in anti-PD-1-refractory Hodgkin lymphoma

Armand P, Zinzani PL, Timmerman JM, Johnson NA, Lavie D, Thiagarajan K, Topp B, Pillai PM, Herrera AF. Estimating efficacy of favezelimab plus pembrolizumab relative[...]